Readout Technologies for Highly Miniaturized Kinase Assays Applicable to High-Throughput Screening in a 1536-Well Format

This article discusses the development of homogeneous, miniaturized assays for the identification of novel kinase inhibitors from very large compound collections. In particular, the suitability of time-resolved fluorescence resonance energy transfer (TR-RET) based on phospho-specific antibodies, an antibody-independent fluorescence polarization (FP) approach using metal-coated beads (IMAP™ technology), and the determination of adenosine triphosphate consumption through chemiluminescence is evaluated. These readouts are compared with regard to assay sensitivity, compound interference, reagent consumption, and performance in a 1536-well format, and practical considerations for their application in primary screening or in the identification of kinase substrates are discussed. All of the tested technologies were found to be suitable for miniaturized high-throughput screening (HTS) in principle, but each of them has distinct limitations and advantages. Therefore, the target-specific selection of the most appropriate readout technology is recommended to ensure maximal relevance of HTS campaigns.

[1]  Zhou Songyang,et al.  Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.

[2]  K. Ervin,et al.  Development and application of fluorescence polarization assays in drug discovery. , 2003, Combinatorial chemistry & high throughput screening.

[3]  R. Seethala,et al.  A fluorescence polarization competition immunoassay for tyrosine kinases. , 1998, Analytical biochemistry.

[4]  James R Beasley,et al.  Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays. , 2004, Assay and drug development technologies.

[5]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[6]  Hervé Bazin,et al.  クリプテート発光の時間分解増幅 生物分子相互作用を追跡するための多才な技術 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2002 .

[7]  P. Cohen.  Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.

[8]  A. Levitzki,et al.  Substrate competitive inhibitors of IGF-1 receptor kinase. , 2000, Biochemistry.

[9]  D. J. Hayes,et al.  Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence , 1998 .

[10]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[11]  J. Corrie,et al.  A fluorescent sensor of the phosphorylation state of nucleoside diphosphate kinase and its use to monitor nucleoside diphosphate concentrations in real time. , 2001, Biochemistry.

[12]  D. Auld,et al.  Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. , 2003, Assay and drug development technologies.

[13]  K. Tsao,et al.  Establishment of ELISA on 384‐well microplate for AFP, CEA, CA 19‐9, CA 15‐3, CA 125, and PSA‐ACT: Higher sensitivity and lower reagent cost , 2003, Journal of clinical laboratory analysis.

[14]  J. Schneider-Mergener,et al.  High-content peptide microarrays for deciphering kinase specificity and biology. , 2004, Angewandte Chemie.

[15]  K. Gumireddy,et al.  A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Sportsman,et al.  Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. , 2004, Assay and drug development technologies.

[17]  K. Rajkowski,et al.  Corrected equations for the calculation of protein-ligand binding results from fluorescence polarization data. , 1981, Journal of theoretical biology.

[18]  Miki N. Newman,et al.  Utilization of Fluorescence Polarization and Time Resolved Fluorescence Resonance Energy Transfer Assay Formats for SAR Studies: Src Kinase as a Model System , 2004, Journal of biomolecular screening.

[19]  B. Druker.  Imatinib as a paradigm of targeted therapies , 2003 .

[20]  S. Manly,et al.  Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening , 1996 .

[21]  R. Seethala,et al.  A homogeneous, fluorescence polarization assay for src-family tyrosine kinases. , 1997, Analytical biochemistry.

[22]  T. Nordström,et al.  Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells. , 2001, Analytical biochemistry.

[23]  W. Patrick Walters,et al.  A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.

[24]  J. J. Wu,et al.  Fluorescence polarization is a useful technology for reagent reduction in assay miniaturization. , 2000, Combinatorial chemistry & high throughput screening.

[25]  Anne J. Ridley,et al.  ROCKs: multifunctional kinases in cell behaviour , 2003, Nature Reviews Molecular Cell Biology.

[26]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[27]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[28]  T. Turek-Etienne,et al.  Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. , 2003, Assay and drug development technologies.

[29]  G. Zaman,et al.  High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.

[30]  Liang Tong,et al.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002 .

[31]  J. Sportsman,et al.  A Homogeneous Fluorescence Polarization Assay Adaptable for a Range of Protein Serine/Threonine and Tyrosine Kinases , 2003, Journal of biomolecular screening.

[32]  M. Kurz,et al.  ADP-specific sensors enable universal assay of protein kinase activity. , 2004, Chemistry & biology.

[33]  Xiao Xu,et al.  Live cell quality control and utility of real-time cell electronic sensing for assay development. , 2006, Assay and drug development technologies.

[34]  T. Okabe,et al.  High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase. , 2004, Assay and drug development technologies.

[35]  A. Ishida,et al.  Firefly bioluminescence assay of ATP using diethylaminoethyl-dextran as an enhancer in the presence of sodium chloride and ATP extranctant. , 2003, Analytical Biochemistry.

[36]  H. Bazin,et al.  Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. , 2002, Journal of biotechnology.

[37]  Holger Wesche,et al.  High throughput screening for protein kinase inhibitors. , 2005, Combinatorial chemistry & high throughput screening.

[38]  J. Albanell,et al.  Small molecules with EGFR-TK inhibitor activity. , 2005, Current drug targets.

[39]  E. Scholar,et al.  Role of Tyrosine Kinase Inhibitors in Cancer Therapy , 2005, Journal of Pharmacology and Experimental Therapeutics.